These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 24029547)

  • 1. External validation of the DRAGON score in an elderly Spanish population: prediction of stroke prognosis after IV thrombolysis.
    Giralt-Steinhauer E; Rodríguez-Campello A; Cuadrado-Godia E; Ois Á; Jiménez-Conde J; Soriano-Tárraga C; Roquer J
    Cerebrovasc Dis; 2013; 36(2):110-4. PubMed ID: 24029547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score.
    Strbian D; Meretoja A; Ahlhelm FJ; Pitkäniemi J; Lyrer P; Kaste M; Engelter S; Tatlisumak T
    Neurology; 2012 Feb; 78(6):427-32. PubMed ID: 22311929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic Resonance Imaging-DRAGON score: 3-month outcome prediction after intravenous thrombolysis for anterior circulation stroke.
    Turc G; Apoil M; Naggara O; Calvet D; Lamy C; Tataru AM; Méder JF; Mas JL; Baron JC; Oppenheim C; Touzé E
    Stroke; 2013 May; 44(5):1323-8. PubMed ID: 23482603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External validation of the ability of the DRAGON score to predict outcome after thrombolysis treatment.
    Ovesen C; Christensen A; Nielsen JK; Christensen H
    J Clin Neurosci; 2013 Nov; 20(11):1635-6. PubMed ID: 24035206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple variables predict miserable outcome after intravenous thrombolysis.
    Seiffge DJ; Karagiannis A; Strbian D; Gensicke H; Peters N; Bonati LH; Kotisaari K; Leppä M; Kejda-Scharler J; Tränka C; Ginsbach P; Tatlisumak T; Lyrer PA; Engelter ST
    Eur J Neurol; 2014 Feb; 21(2):185-91. PubMed ID: 24010545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting stroke outcome using clinical- versus imaging-based scoring system.
    Baek JH; Kim K; Lee YB; Park KH; Park HM; Shin DJ; Sung YH; Shin DH; Bang OY
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):642-8. PubMed ID: 25576347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
    Kono S; Deguchi K; Morimoto N; Kurata T; Yamashita T; Ikeda Y; Narai H; Manabe Y; Takao Y; Kawada S; Kashihara K; Takehisa Y; Inoue S; Kiriyama H; Abe K
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
    Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcome.
    Paliwal PR; Ahmad A; Shen L; Yeo LL; Loh PK; Ng KW; Chong VF; Ong BK; Venketasubramanian N; Sinha AK; Teoh HL; Bathla G; Chan BP; Sharma VK
    Cerebrovasc Dis; 2012; 33(5):446-52. PubMed ID: 22456065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the DRAGON Score in a Chinese Population to Predict Functional Outcome of Intravenous Thrombolysis-Treated Stroke Patients.
    Zhang X; Liao X; Wang C; Liu L; Wang C; Zhao X; Pan Y; Wang Y; Wang Y
    J Stroke Cerebrovasc Dis; 2015 Aug; 24(8):1755-60. PubMed ID: 26028300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation assessment of risk tools to predict outcome after thrombolytic therapy for acute ischemic stroke.
    Van Hooff RJ; Nieboer K; De Smedt A; Moens M; De Deyn PP; De Keyser J; Brouns R
    Clin Neurol Neurosurg; 2014 Oct; 125():189-93. PubMed ID: 25171393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of blood pressure and collateral circulation in hyperacute ischemic stroke patients treated with intravenous thrombolysis.
    Rusanen H; Saarinen JT; Sillanpää N
    Cerebrovasc Dis; 2015; 39(2):130-7. PubMed ID: 25660943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment.
    Nesi M; Lucente G; Nencini P; Fancellu L; Inzitari D
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):204-8. PubMed ID: 23352114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of admission serum glucose on the clinical prognosis of patients with acute ischemic stroke receiving alteplase intravenous thrombolysis.
    Huang P; Yi X
    Int J Immunopathol Pharmacol; 2023; 37():3946320231204597. PubMed ID: 37771034
    [No Abstract]   [Full Text] [Related]  

  • 17. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
    Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D;
    JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
    Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The totaled health risks in vascular events (THRIVE) score predicts ischemic stroke outcomes independent of thrombolytic therapy in the NINDS tPA trial.
    Kamel H; Patel N; Rao VA; Cullen SP; Faigeles BS; Smith WS; Flint AC
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1111-6. PubMed ID: 23122722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.